Thomas Pfisterer, Director at ADC Therapeutics SA (ADCT), sold 1,437 shares at $2.89 ($4K) on 2024-06-17, disclosed to the SEC on 2024-06-18.
Open-market sale of $4k ADCT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.